Anaesthetic Management Of A Patient With Giant Cell Tumour Of Mandible With Rheumatic Heart Disease With Mitral Regurgitation With Epilepsy For Excision

10.5580/7a4 ◽  
2009 ◽  
Vol 20 (2) ◽  
Keyword(s):  
Heart Disease ◽  
Mitral Regurgitation ◽  
Giant Cell ◽  
Rheumatic Heart Disease ◽  
Giant Cell Tumour ◽  
Anaesthetic Management ◽  
Cell Tumour ◽  
Rheumatic Heart

scholarly journals Anaesthetic management of a young primigravida with 8 months amenorrhea, rheumatic heart disease, hypothyroidism and met-hemoglobinimea schedule for cesarean section

2020 ◽  
Vol 9 (6) ◽  
pp. 2602
Author(s):  
Misha Katyal
Keyword(s):  
Methylene Blue ◽  
Ascorbic Acid ◽  
Heart Disease ◽  
General Anesthesia ◽  
Rheumatic Heart Disease ◽  
Good Alternative ◽  
Anaesthetic Management ◽  
Supplemental Oxygen ◽  
Postoperative Treatment ◽  
Rheumatic Heart

A young patient, primigravida with rheumatic heart disease, hypothyroidism and met-hemoglobinemia had central and peripheral cyanosis was scheduled for caesarean section under general anesthesia in two days. Author managed met-hemoglobinemia with ascorbic acid keeping methylene blue as standby. Haemoglobin saturation was 89% at room air and 92% with supplemental oxygen. Initial met-haemoglobin levels were 31.54% (normal values <1%). After optimizing thyroid and RHD status (moderate MR and mild MS), she was given tablet ascorbic acid 2 gram thrice a day with methylene blue as standby. Conventional balanced general anesthesia technique was used and she was followed up in postoperative period with ICU care. A healthy live female baby was extracted and mother had stable vital parameters. Postoperative treatment with ascorbic acid was continued. Repeated methaemoglobin levels showed a drop from preoperative value of 31.54% to 11.39% by 3rd postoperative day and 8.05% at the end of 1st week. At the time of discharge, she did not have any cyanosis. Ascorbic acid is a good alternative drug with limited experience in met-hemoglobinemia. Author present a case of a met-hemoglobinemia treated with ascorbic acid successfully to emphasize the use of ascorbic acid as an alternative method without any adverse effects.

Echocardiographic screening of pregnant women by non-physicians with remote interpretation in primary care

2020 ◽  
Author(s):  
Bruno R Nascimento ◽  
Craig Sable ◽  
Maria Carmo P Nunes ◽  
Kaciane K B Oliveira ◽  
Juliane Franco ◽  
...  
Keyword(s):  
Primary Care ◽  
Heart Disease ◽  
Mitral Valve ◽  
Mitral Regurgitation ◽  
Pregnant Women ◽  
Rheumatic Heart Disease ◽  
Morphological Changes ◽  
Severe Disease ◽  
Left Ventricular ◽  
Rheumatic Heart

Abstract Background Impact of heart disease (HD) on pregnancy is significant. Objective We aimed to evaluate the feasibility of integrating screening echocardiography (echo) into the Brazilian prenatal primary care to assess HD prevalence. Methods Over 13 months, 20 healthcare workers acquired simplified echo protocols, utilizing hand-held machines (GE-VSCAN), in 22 primary care centres. Consecutive pregnant women unaware of HD underwent focused echo, remotely interpreted in USA and Brazil. Major HD was defined as structural valve abnormalities, more than mild valve dysfunction, ventricular systolic dysfunction/hypertrophy, or other major abnormalities. Screen-positive women were referred for standard echo. Results At total, 1 112 women underwent screening. Mean age was 27 ± 8 years, mean gestational age 22 ± 9 weeks. Major HD was found in 100 (9.0%) patients. More than mild mitral regurgitation was observed in 47 (4.2%), tricuspid regurgitation in 11 (1.0%), mild left ventricular dysfunction in 4 (0.4%), left ventricular hypertrophy in 2 (0.2%) and suspected rheumatic heart disease in 36 (3.2%): all, with mitral valve and two with aortic valve (AV) involvement. Other AV disease was observed in 11 (10%). In 56 screen-positive women undergoing standard echo, major HD was confirmed in 45 (80.4%): RHD findings in 12 patients (all with mitral valve and two with AV disease), mitral regurgitation in 40 (14 with morphological changes, 10 suggestive of rheumatic heart disease), other AV disease in two (mild/moderate regurgitation). Conclusions Integration of echo screening into primary prenatal care is feasible in Brazil. However, the low prevalence of severe disease urges further investigations about the effectiveness of the strategy.

scholarly journals Anaesthetic Management of a Case of Pregnancy with Rheumatic Heart Disease

2021 ◽  
Vol 6 (3) ◽  
pp. 278-280
Author(s):  
Shallu Chaudhary ◽  
Neha Atwal
Keyword(s):  
Heart Disease ◽  
Case Report ◽  
Rheumatic Heart Disease ◽  
Mitral Stenosis ◽  
Intraoperative Monitoring ◽  
Low Dose ◽  
Anaesthetic Management ◽  
Emergency Caesarean Section ◽  
Intravenous Fluids ◽  
Rheumatic Heart

We present a case report of a 28 year old pregnant female with moderate mitral stenosis who was posted for emergency caesarean section. The patient was given low dose subarachnoid block with injection bupivacaine (H) 7.5 mg and injection fentanyl 20 micrograms. Adequate intraoperative monitoring, optimum sedation, analgesia, oxygenation was done. Judicious use of intravenous fluids was considered. The patient maintained smooth intraoperative vitals. Postoperatively also the patient was monitored in the ICU and adequate analgesia was provided. Keywords: Rheumatic Heart Disease, Anaesthetic Management, Pregnancy, Mitral stenosis of rheumatic origin

Penicillin and Acute Rheumatic Fever

PEDIATRICS ◽  
1982 ◽  
Vol 70 (3) ◽  
pp. 506-507
Author(s):  
Bernard Boxerbaum
Keyword(s):  
Heart Disease ◽  
Mitral Regurgitation ◽  
Rheumatic Fever ◽  
Rheumatic Heart Disease ◽  
Acute Rheumatic Fever ◽  
Secondary Prophylaxis ◽  
Benzathine Penicillin ◽  
Childrens Hospital ◽  
Rheumatic Heart

Introduction of secondary prophylaxis for patients with rheumatic fever is felt to be a major reason for improved prognosis of rheumatic heart disease.1,2(p163) The article by Ginsburg et al,3 raising questions concerning the efficacy of this practice, has prompted me to report our experience in the Rainbow Rheumatic Fever Clinic, Rainbow Babies and Childrens Hospital, where more than 80% of the patients receive 1,200,000 units of benzathine penicillin intramuscularly every 28 days. Seventy percent of the patients with rheumatic mitral regurgitation have lost their murmur, and no patient receiving regular intramuscular prophylaxis has developed stenosis.4

scholarly journals A Case Presentation on Rheumatic Heart Disease with Mitral Regurgitation

2019 ◽  
Vol 09 (01) ◽  
pp. 28-30
Author(s):  
Jayasudha A. ◽  
Sreerenjini B. ◽  
Kaveri P. ◽  
Anitha P.
Keyword(s):  
Heart Disease ◽  
Mitral Regurgitation ◽  
Rheumatic Heart Disease ◽  
Heart Valves ◽  
Multidisciplinary Approach ◽  
Well Being ◽  
Case Presentation ◽  
The Right ◽  
Rheumatic Heart ◽  
Increased Pressure

AbstractDuring any pregnancy there is an increase in blood volume of 30 to 50% resulting in increased pressure on the heart valves. For women with rheumatic heart disease this increased pressure presents increased maternal and/or fetal risks. Counseling of women with rheumatic heart disease gives appropriate surveillance of maternal and fetal well-being, as well as planning and documentation of the management of elective and emergency delivery. The care of pregnant women with rheumatic heart disease thus requires a multidisciplinary approach, involving obstetricians, cardiologists, and anesthetists. However, many women with rheumatic heart disease have healthy pregnancies and healthy babies with the right medical care.

scholarly journals Effect of Mitral Regurgitation on Systemic Coagulation Activity in Rheumatic Heart Disease as Assessed by D-dimer Levels

Cureus ◽  
2021 ◽  
Author(s):  
Abhishek Goyal ◽  
Puneet Aggarwal ◽  
Abhinav Shrivastava ◽  
Bhagya Narayan Pandit ◽  
Saibal Mukhopadhyay ◽  
...  
Keyword(s):  
Heart Disease ◽  
Mitral Regurgitation ◽  
Rheumatic Heart Disease ◽  
Coagulation Activity ◽  
D Dimer ◽  
Rheumatic Heart
Sign in / Sign up

Export Citation Format

Share Document